Likewise, it has been experimentally shown that apolipoprotein E (APOE), a risk factor for AD, activates the pro-inflammatory cyclophilin A-nuclear factor-κM-matrix-metalloproteinase-9 pathway in pericytes, leading to BBB impairment [19]. This evidence concerns the gene APOE and Alzheimer disease.